| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 05/06/2004 | EP1416017A1 Fluorescent nucleosides, nucleotides or polynucleotides containing a rhodamine dye |
| 05/06/2004 | EP1415995A2 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 05/06/2004 | EP1415001A2 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof |
| 05/06/2004 | EP1414837A1 Adenosine a3 receptor agonists |
| 05/06/2004 | EP1414836A2 Process for the preparation of l-ribavirin |
| 05/06/2004 | EP1414797A2 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 05/06/2004 | EP1414441A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 05/06/2004 | EP1272501B1 Process for the preparation of phosphorothioate triesters |
| 05/05/2004 | CN1494550A Process for preparation of (E)-5-(2-bromovinyl) -2'-deoxyuridine |
| 05/05/2004 | CN1494549A Avermectins substituted in 4'-position having pesticidal properties |
| 05/05/2004 | CN1493580A Ibuprofen ribavirin ester and preparation method and use thereof |
| 04/29/2004 | WO2004035599A1 Phosphitylation process |
| 04/29/2004 | US20040082776 Chromatography; elution using anionic and cationic exchanger |
| 04/29/2004 | US20040082775 Dissolving of raw materials; solvent extraction |
| 04/29/2004 | US20040082774 Novel phosphate and thiophosphate protecting groups |
| 04/29/2004 | US20040082635 Fused cyclic compounds and medicinal use thereof |
| 04/29/2004 | US20040082525 Avermectins substituted in the 4"-position having pesticidal properties |
| 04/28/2004 | EP1412370A1 Nucleoside pyrophosphate and triphosphate analogs and related compounds as therapeutic agents |
| 04/28/2004 | EP1412369A2 Process for preparing purine nucleosides |
| 04/28/2004 | EP1411954A2 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 04/28/2004 | EP1411928A1 Viral polymerase inhibitors |
| 04/28/2004 | EP1017703B1 Pentopyranosyl nucleoside, and production and use of the same |
| 04/28/2004 | EP0513200B2 Method and compositions for the synthesis of bch-189 and related compounds |
| 04/28/2004 | CN1147502C Method for large-scale production of Di (uridine 5'-tetraphosphate) and salts thereof |
| 04/28/2004 | CN1147501C Process for preparing nucleotide |
| 04/27/2004 | US6728383 Method of compensating for hearing loss |
| 04/27/2004 | US6727278 Pharmaceutically active agents that impede amyloid formation in vivo |
| 04/27/2004 | US6727232 Nucleoside peptide antibiotics of AA-896 |
| 04/27/2004 | US6727231 Effective to improve one or more of the symptoms of autistic disorder |
| 04/27/2004 | US6727059 Method for controlling the fidelity and processivity of reverse transcriptase by incorporation and polymerization of nucleotide analogs accepted as substrates for the reverse transcription reaction without blocking its elongation |
| 04/27/2004 | US6726911 Biologically active compounds of Ganoderma pfeifferi DSM 13239 |
| 04/22/2004 | WO2003064625A3 Oligonucleotide compositions with enhanced efficiency |
| 04/22/2004 | US20040077672 Anticarcinogenic, antiproliferative, and antitumor agents |
| 04/22/2004 | US20040077588 Proliferation inhibition of pathological cells; prodrug converted to or releasing cellular toxin |
| 04/22/2004 | US20040077587 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| 04/22/2004 | US20040077586 Bromination, dehydrobromination and deprotecting of 5-ethyl-hydroxyprotected derivative in halogen free solvent at high yield |
| 04/22/2004 | US20040077585 Using P2Y receptor agonists with enhanced resistance to extracellular hydrolysis; such as dinucleoside polyphosphate compounds |
| 04/22/2004 | US20040077584 2-Aminocarbonyl-9H-purine derivatives |
| 04/22/2004 | US20040077564 Ring expanded nucleosides and nucleotides |
| 04/22/2004 | US20040077554 Topoisomerase I inhibitors; such as 2,3-methylenedioxy-6-hydroxymethyl-9-hydroxy-12-(beta-D-glucopyranosyl) -6,7,12,13-tetrahydroindolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7-dione |
| 04/22/2004 | US20040076971 UV excitable fluorescent energy transfer dyes |
| 04/21/2004 | EP1411059A1 Method for producing mixed crystal of disodium 5'-guanylate and disodium 5'-inosinate |
| 04/21/2004 | EP1411057A1 [3,4-a:3,4-c]carbazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/21/2004 | EP1409731A2 Methods of modulating pharmacokinetics of oligonucleotides |
| 04/21/2004 | EP1409503A1 Non-natural carbon-linked nucleotides and dinucleotides |
| 04/21/2004 | EP1409497A2 Method for preparation of lna phosphoramidites |
| 04/21/2004 | EP1409486A1 Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives |
| 04/21/2004 | CN1490322A Ansi glycoside compound and its medicinal composition, preparation and use |
| 04/21/2004 | CN1146573C Novel arabinosyladenine derivatives |
| 04/20/2004 | US6723515 Polyamide for use tool in the adjustment of the migration of nucleotide sequences during electrophoresis |
| 04/20/2004 | US6723321 Modulation of lyase activity; obtain sample containing lyase, incubate with substrate and modulator, monitor adjustment in binding of substrate to lyase, adjustment in binding indicates modulator |
| 04/20/2004 | CA2098874C Stereoselective anion glycosylation process |
| 04/16/2004 | CA2443585A1 New derivatives of (3,4-a:3,4-c) carbazole, their preparation process, and pharmaceutical compositions that contain them |
| 04/15/2004 | WO2004031405A1 Substrates for o6-alkylguanine-dna alkyltransferase |
| 04/15/2004 | WO2004003210A3 Selective functionalization of hydrocarbons with isolated oxygenases and mediator based regeneration |
| 04/15/2004 | WO2002100354B1 Pyrrolo[2,3-d]pyrimidine nucleoside analogs |
| 04/15/2004 | US20040072788 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/15/2004 | US20040072303 Method of preparing a guanosine-group compound and an intermediate thereof |
| 04/15/2004 | US20040072234 High affinity nucleic acid ligands to lectins |
| 04/15/2004 | US20040072209 Methods of labelling polynucleotides with dibenzorhodamine dyes |
| 04/15/2004 | CA2501063A1 Substrates for o6-alkylguanine-dna alkyltransferase |
| 04/14/2004 | EP1408090A1 Dibenzorhodamine dyes useful as fluorescent labelling agents |
| 04/14/2004 | EP1407053A2 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith |
| 04/14/2004 | EP1406667A2 METHODS FOR INCREASING i IN VIVO /i EFFICACY OF OLIGONUCLEOTIDES AND INHIBITING INFLAMMATION IN MAMMALS |
| 04/14/2004 | EP1406636A2 System and method for the large scale labeling of compounds with radiohalogens |
| 04/14/2004 | CN1488353A Composition for treating ischemic disease |
| 04/08/2004 | WO2004028481A2 Nucleoside derivatives for treating hepatitis c virus infection |
| 04/08/2004 | WO2004028462A2 Method for the preparation of 2-halo-2'-deoxyadenosine compounds from 2'-deoxyguanosine |
| 04/08/2004 | WO2004028454A2 1, 3, 5-triazines for treatment of viral diseases |
| 04/08/2004 | WO2004022573A3 Adenosine a3 receptor agonists |
| 04/08/2004 | WO2004016635A3 Partial and full agonists of a1 adenosine receptors |
| 04/08/2004 | WO2004007512A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 04/08/2004 | WO2003107144A3 Systems and methods for predicting oligonucleotide melting temperatures (tms) |
| 04/08/2004 | WO2003072586A3 Methods of producing phosphitylated compounds |
| 04/08/2004 | WO2003014139B1 Therapeutic compositions and screening methods relating to 3'-tyrosyl-dna-phosphodiesterase |
| 04/08/2004 | US20040068107 Method for the production of pentopyranosly nucleosides |
| 04/08/2004 | US20040067901 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/08/2004 | US20040067900 Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations |
| 04/08/2004 | US20040067877 Hepatitis virus infections |
| 04/08/2004 | US20040067565 Oxofunctionalized hydrocarbons are important synthons e.g. for the synthesis of various pharmaceutically relevant compounds |
| 04/08/2004 | US20040067558 Used as a raw material of an anti-virus agent, antisense medicine |
| 04/08/2004 | US20040067521 Sequence specific recognition reagents (oligonucleotide, monoclonal antibodies) attached to a solid substrate; sequencing, fingerprinting and mapping biological polymers |
| 04/08/2004 | US20040067498 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures |
| 04/08/2004 | US20040067228 O-acetyl-ADP ribose, a histone deacetylase-reaction product, used for producing polyclonal or monoclonal antibodies, and for analysis by competitive binding assaying of aging resistance and/or anticarcinogenic agents |
| 04/08/2004 | CA2499253A1 Nucleoside derivatives for treating hepatitis c virus infection |
| 04/08/2004 | CA2499036A1 1,3,5-triazines for treatment of viral diseases |
| 04/07/2004 | EP1404694A1 Nucleoside compounds in hcv |
| 04/07/2004 | EP1404347A2 4'-substituded nucleosides for the treatment of diseases mediated by the hepatitis c virus |
| 04/07/2004 | EP1404338A1 Adenosine analogues for the treatment of the insulin resistance syndrome and diabetes |
| 04/07/2004 | EP1303282A4 Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides |
| 04/07/2004 | EP1272655A4 Stabilization of highly sensitive nucleic acid stains in aqueous solutions |
| 04/07/2004 | EP1150991B1 Compositions for treating inflammatory response |
| 04/07/2004 | CN1487949A Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same |
| 04/07/2004 | CN1144587C Agents for relieving side effects |
| 04/06/2004 | US6716825 Osteoporosis and other disorders of bone metabolisum, cancer, viral infections, and the like. |
| 04/06/2004 | US6716596 Agents for replacement of NAD+/NADH system in enzymatic reactions |
| 04/06/2004 | US6716583 Methods of producing nucleic acid ligands |
| 04/01/2004 | WO2004027080A2 Method of extracting nucleic acids from microbial samples |
| 04/01/2004 | WO2004026890A1 Acetylene compounds |
| 04/01/2004 | WO2004013298A3 2',3'-dideoxynucleoside analogues for the treatment or prevention of flavivitridae infections |